In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

New module addresses multi-billion-dollar data quality challenge in life sciences by automating data cleansing, standardization, and transformation for AI readiness ...

US FDA 200+CRLs to help pharma industry engage in a more transparent manner: Experts: Shardul Nautiyal, Mumbai Friday, July 18, 2025, 08:00 Hrs [IST] US FDA 200+Complete Response ...

Real change takes a long time, and when it happens, it must be recognized. The FDA and the NIH have announced their move away ...

At the Mount Sinai Health System we have successfully translated many algorithms from concept to testing and clinical care, in ways that have led to financial savings and improved patient outcomes.

Oracle co-founder Larry Ellison has climbed past Mark Zuckerberg to become the world’s second-richest person, following a ...

Investment management company Vulcan Value Partners recently released its second-quarter 2025 investor letter. A copy of the ...

Chances are, most people are familiar with the term, “population health.” After all, the concept has rapidly gained popularity over the past ...

As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Drug development is a decade-long, costly process replete with failures. If we don’t incentivize investments in research and ...

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that affects motor neurons, leading to ...